Company profile for Silo Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Silo Pharma Inc’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry. In these uncertain times, the mental health of the nation and beyond is being put to the test. More than ever, creative new therapies and lines of thought are needed to address health challenges of today. Combining our resources with world-class m...
Silo Pharma Inc’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry. In these uncertain times, the mental health of the nation and beyond is being put to the test. More than ever, creative new therapies and lines of thought are needed to address health challenges of today. Combining our resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Englewood Cliffs, New Jersey
Telephone
Telephone
201-408-5126
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/17/3189119/0/en/Silo-Pharma-Partners-with-Allucent-to-Support-Planned-FDA-Investigational-New-Drug-Application-for-SPC-15-as-a-Therapeutic-for-PTSD.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/10/29/3176423/0/en/Silo-Pharma-Selects-Alphaledger-s-T12-Fund-for-Tokenized-Real-World-Asset-Investments-on-Solana-Blockchain.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/10/23/3172053/0/en/Silo-Pharma-Issues-Update-on-Milestone-Achievements-in-PTSD-Drug-Development-and-New-Digital-Assets-Treasury-Program.html

GLOBENEWSWIRE
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/08/3163367/0/en/Silo-Pharma-Expands-Crypto-Treasury-with-First-Strategic-Bitcoin-Purchase-Reinforcing-Company-s-Commitment-to-Multi-Chain-Growth.html

GLOBENEWSWIRE
08 Oct 2025

https://www.globenewswire.com/news-release/2025/10/06/3161691/0/en/Silo-Pharma-Acquires-ResearchCoin-RSC-Crypto-Tokens-in-Support-of-Decentralized-Science-DeSci.html

GLOBENEWSWIRE
06 Oct 2025

https://www.globenewswire.com/news-release/2025/10/01/3159965/0/en/Silo-Pharma-Announces-Closing-of-2-5-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html

GLOBENEWSWIRE
01 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty